﻿<?xml version="1.0" encoding="utf-8"?>
<Return xmlns="http://www.irs.gov/efile" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" returnVersion="2023v6.0">
  <ReturnHeader binaryAttachmentCnt="0">
    <ReturnTs>2025-08-14T11:52:37-04:00</ReturnTs>
    <TaxPeriodEndDt>2024-09-30</TaxPeriodEndDt>
    <PreparerFirmGrp>
      <PreparerFirmEIN>460952065</PreparerFirmEIN>
      <PreparerFirmName>
        <BusinessNameLine1Txt>BOUNTIFUL PEAK ADVISORS</BusinessNameLine1Txt>
      </PreparerFirmName>
      <PreparerUSAddress>
        <AddressLine1Txt>1564 SOUTH 500 WEST SUITE 201</AddressLine1Txt>
        <CityNm>BOUNTIFUL</CityNm>
        <StateAbbreviationCd>UT</StateAbbreviationCd>
        <ZIPCd>840107400</ZIPCd>
      </PreparerUSAddress>
    </PreparerFirmGrp>
    <ReturnTypeCd>990</ReturnTypeCd>
    <TaxPeriodBeginDt>2023-10-01</TaxPeriodBeginDt>
    <Filer>
      <EIN>237088244</EIN>
      <BusinessName>
        <BusinessNameLine1Txt>ACADEMY OF CLINICAL LABORATORY</BusinessNameLine1Txt>
        <BusinessNameLine2Txt>PHYSICIANS AND SCIENTISTS</BusinessNameLine2Txt>
      </BusinessName>
      <BusinessNameControlTxt>ACAD</BusinessNameControlTxt>
      <PhoneNum>8015832787</PhoneNum>
      <USAddress>
        <AddressLine1Txt>500 CHIPETA WAY</AddressLine1Txt>
        <CityNm>SALT LAKE CITY</CityNm>
        <StateAbbreviationCd>UT</StateAbbreviationCd>
        <ZIPCd>841081221</ZIPCd>
      </USAddress>
    </Filer>
    <BusinessOfficerGrp>
      <PersonNm>TATIANA YUZYUK PHD</PersonNm>
      <PersonTitleTxt>TREASURER</PersonTitleTxt>
      <PhoneNum>8015832787</PhoneNum>
      <SignatureDt>2025-06-25</SignatureDt>
      <DiscussWithPaidPreparerInd>true</DiscussWithPaidPreparerInd>
    </BusinessOfficerGrp>
    <IRSResponsiblePrtyInfoCurrInd>true</IRSResponsiblePrtyInfoCurrInd>
    <PreparerPersonGrp>
      <PreparerPersonNm>JUSTIN R SHAW CPA CFE CGMA</PreparerPersonNm>
      <PTIN>P00081558</PTIN>
      <PhoneNum>8012943155</PhoneNum>
      <PreparationDt>2025-08-14</PreparationDt>
    </PreparerPersonGrp>
    <TaxYr>2023</TaxYr>
    <BuildTS>2025-03-06 01:10:19Z</BuildTS>
  </ReturnHeader>
  <ReturnData documentCnt="5">
    <IRS990 documentId="RetDoc1" referenceDocumentId="RetDoc4">
      <PrincipalOfficerNm>TATIANA YUZYUK PHD</PrincipalOfficerNm>
      <USAddress>
        <AddressLine1Txt>500 CHIPETA WAY</AddressLine1Txt>
        <CityNm>SALT LAKE CITY</CityNm>
        <StateAbbreviationCd>UT</StateAbbreviationCd>
        <ZIPCd>841081221</ZIPCd>
      </USAddress>
      <GrossReceiptsAmt>81880</GrossReceiptsAmt>
      <GroupReturnForAffiliatesInd>false</GroupReturnForAffiliatesInd>
      <Organization501c3Ind>X</Organization501c3Ind>
      <WebsiteAddressTxt>WWW.ACLPS.ORG</WebsiteAddressTxt>
      <TypeOfOrganizationCorpInd>X</TypeOfOrganizationCorpInd>
      <FormationYr>1994</FormationYr>
      <LegalDomicileStateCd>UT</LegalDomicileStateCd>
      <ActivityOrMissionDesc>OUR ACADEMY WAS FOUNDED IN 1966 AND CURRENTLY HAS ACTIVE AFFILIATIONS WITH 70 OF THE APPROXIMATELY 150 ACADEMIC AND COMMUNITY TRAINING CENTERS THAT TRAIN PATHOLOGY RESIDENTS IN CLINICAL PATHOLOGY. FROM ITS ORIGIN, IT HAS FOLLOWED THE MISSION STATEMENT OF BEING DEDICATED TO THE ADVANCEMENT OF TEACHING AND SCHOLARSHIP IN LABORATORY MEDICINE. WE FOLLOW THE OBJECTIVES OF THE ACADEMY. SINCE ITS INCEPTION, THIS DEDICATION HAS BEEN DRIVEN BY THE FOLLOWING OBJECTIVES: 1. TO ENCOURAGE AND ADVANCE THE HIGHEST STANDARDS OF EDUCATION IN LABORATORY MEDICINE IN MEDICAL SCHOOL AND RELATED CURRICULA. 2. TO ENCOURAGE AND PROMOTE THE HIGHEST STANDARDS OF RESIDENT TRAINING AND POST-GRADUATE EDUCATION OF PHYSICIANS AND SCIENTISTS IN CLINICAL PATHOLOGY AT UNIVERSITIES AND MEDICAL SCHOOLS. 3. TO ENCOURAGE AND PROMOTE THE HIGHEST STANDARDS OF SERVICE, EDUCATION AND RESEARCH IN ACADEMIC LABORATORY MEDICINE.</ActivityOrMissionDesc>
      <VotingMembersGoverningBodyCnt>6</VotingMembersGoverningBodyCnt>
      <VotingMembersIndependentCnt>6</VotingMembersIndependentCnt>
      <TotalEmployeeCnt>0</TotalEmployeeCnt>
      <TotalGrossUBIAmt>0</TotalGrossUBIAmt>
      <PYContributionsGrantsAmt>1150</PYContributionsGrantsAmt>
      <CYContributionsGrantsAmt>2154</CYContributionsGrantsAmt>
      <PYProgramServiceRevenueAmt>40550</PYProgramServiceRevenueAmt>
      <CYProgramServiceRevenueAmt>39450</CYProgramServiceRevenueAmt>
      <PYInvestmentIncomeAmt>32322</PYInvestmentIncomeAmt>
      <CYInvestmentIncomeAmt>40276</CYInvestmentIncomeAmt>
      <CYOtherRevenueAmt>0</CYOtherRevenueAmt>
      <PYTotalRevenueAmt>74022</PYTotalRevenueAmt>
      <CYTotalRevenueAmt>81880</CYTotalRevenueAmt>
      <CYGrantsAndSimilarPaidAmt>25300</CYGrantsAndSimilarPaidAmt>
      <CYBenefitsPaidToMembersAmt>0</CYBenefitsPaidToMembersAmt>
      <CYSalariesCompEmpBnftPaidAmt>0</CYSalariesCompEmpBnftPaidAmt>
      <CYTotalProfFndrsngExpnsAmt>0</CYTotalProfFndrsngExpnsAmt>
      <CYTotalFundraisingExpenseAmt>0</CYTotalFundraisingExpenseAmt>
      <PYOtherExpensesAmt>69967</PYOtherExpensesAmt>
      <CYOtherExpensesAmt>62495</CYOtherExpensesAmt>
      <PYTotalExpensesAmt>69967</PYTotalExpensesAmt>
      <CYTotalExpensesAmt>87795</CYTotalExpensesAmt>
      <PYRevenuesLessExpensesAmt>4055</PYRevenuesLessExpensesAmt>
      <CYRevenuesLessExpensesAmt>-5915</CYRevenuesLessExpensesAmt>
      <TotalAssetsBOYAmt>1428542</TotalAssetsBOYAmt>
      <TotalAssetsEOYAmt>1687016</TotalAssetsEOYAmt>
      <TotalLiabilitiesEOYAmt>0</TotalLiabilitiesEOYAmt>
      <NetAssetsOrFundBalancesBOYAmt>1428542</NetAssetsOrFundBalancesBOYAmt>
      <NetAssetsOrFundBalancesEOYAmt>1687016</NetAssetsOrFundBalancesEOYAmt>
      <InfoInScheduleOPartIIIInd>X</InfoInScheduleOPartIIIInd>
      <MissionDesc>OUR ACADEMY WAS FOUNDED IN 1966 AND CURRENTLY HAS ACTIVE AFFILIATIONS WITH 70 OF THE APPROXIMATELY 150 ACADEMIC AND COMMUNITY TRAINING CENTERS THAT TRAIN PATHOLOGY RESIDENTS IN CLINICAL PATHOLOGY. FROM ITS ORIGIN, IT HAS FOLLOWED THE MISSION STATEMENT OF BEING DEDICATED TO THE ADVANCEMENT OF TEACHING AND SCHOLARSHIP IN LABORATORY MEDICINE. WE FOLLOW THE OBJECTIVES OF THE ACADEMY. SINCE ITS INCEPTION, THIS DEDICATION HAS BEEN DRIVEN BY THE FOLLOWING OBJECTIVES: 1. TO ENCOURAGE AND ADVANCE THE HIGHEST STANDARDS OF EDUCATION IN LABORATORY MEDICINE IN MEDICAL SCHOOL AND RELATED CURRICULA. 2. TO ENCOURAGE AND PROMOTE THE HIGHEST STANDARDS OF RESIDENT TRAINING AND POST-GRADUATE EDUCATION OF PHYSICIANS AND SCIENTISTS IN CLINICAL PATHOLOGY AT UNIVERSITIES AND MEDICAL SCHOOLS. 3. TO ENCOURAGE AND PROMOTE THE HIGHEST STANDARDS OF SERVICE, EDUCATION AND RESEARCH IN ACADEMIC LABORATORY MEDICINE.</MissionDesc>
      <SignificantNewProgramSrvcInd>false</SignificantNewProgramSrvcInd>
      <SignificantChangeInd>false</SignificantChangeInd>
      <ExpenseAmt>79435</ExpenseAmt>
      <GrantAmt>25300</GrantAmt>
      <RevenueAmt>39450</RevenueAmt>
      <Desc>DURING THE YEAR THAT ENDED SEPTEMBER 30, 2024, THE ACADEMY PROVIDED SERVICES TO APPROXIMATELY 379 ACTIVE MEMBERS AND 218 ASSOCIATE MEMBERS. CLOSE TO 200 INDIVIDUALS ATTENDED THE ACLPS ANNUAL MEETING ("LAB MEDICINE") IN NEW YORK CITY, NY, ON JUNE 6-8, 2024. THE MEETING WAS HOSTED BY THE COLUMBIA UNIVERSITY DEPARTMENT OF PATHOLOGY. OVER THE THREE DAYS, CONFERENCE ATTENDEES ENJOYED SCIENTIFIC SESSIONS, THE AWARD LECTURES FROM THE COTLOVE AND BENSON AWARDEES, PRESENTATIONS FROM THE YOUNG INVESTIGATOR AWARD WINNERS, THE YOUNG FACULTY AWARD WINNERS AND THE STRANDJORD GRANT AWARDEES, AND A POSTER SESSION. THE REGISTRATION FOR THIS MEETING WAS 725 FOR ACTIVE MEMBERS AND 650 FOR ASSOCIATE MEMBERS. THE COTLOVE AWARD WAS PRESENTED TO DR. DAVID HO, WHO UPDATED THE AUDIENCE ON THE CONTINUING EVOLUTION OF COVID-19 AND HIV. THE BENSON AWARD WAS PRESENTED TO DR. CHRISTOPHER FARNSWORTH WHO SPOKE ON "NOVEL METHODS FOR REDUCING PREANALYTICAL LABORATORY ERROR." THE ACADEMY ALSO CONTINUED THE PAUL E. STRANDJORD YOUNG INVESTIGATOR GRANT PROGRAM THIS YEAR AND PROVIDED THREE 7,500 RESEARCH GRANTS TO PROGRAM AWARDEES IN 2024. ACLPS HAD INITIATED A SERIES OF REVIEW ARTICLES TITLED "ACLPS CRITICAL REVIEWS" PUBLISHED IN AJCP TO REVIEW RELEVANT TOPICS IN THE FIELD OF LABORATORY MEDICINE. IN ADDITION, AS A MEMBER OF THE RISE FIRST CLINICAL PATHOLOGY SECTION, ACLPS EDUCATION COMMITTEE VETTED QUESTIONS FOR THE CLINICAL PATHOLOGY PORTION OF THE EXAM. ACLPS CONTINUED TO SUPPORT CO-SPONSORED EDUCATIONAL SESSIONS AT THE ASCP ANNUAL MEETING. IT IS USUALLY A ONE-HOUR SESSION HIGHLIGHTING EDUCATIONAL TOPICS AND/OR INNOVATIVE RESEARCH IN THE FIELD OF LABORATORY MEDICINE. THE 2024 SPEAKER WAS SEAN STOWELL M.D, PHD WHO GAVE AN EXCELLENT TALK ON ESTABLISHING A NATIONAL BLOOD BANK ALLOANTIBODY REGISTRY. ACLPS CONTINUES TO PROVIDE EDUCATIONAL REVIEW ARTICLES FOR PUBLICATION IN THE AMERICAN JOURNAL OF CLINICAL PATHOLOGY (AJCP).</Desc>
      <TotalProgramServiceExpensesAmt>79435</TotalProgramServiceExpensesAmt>
      <DescribedInSection501c3Ind referenceDocumentId="RetDoc5">true</DescribedInSection501c3Ind>
      <ScheduleBRequiredInd>false</ScheduleBRequiredInd>
      <PoliticalCampaignActyInd>false</PoliticalCampaignActyInd>
      <LobbyingActivitiesInd>false</LobbyingActivitiesInd>
      <SubjectToProxyTaxInd>false</SubjectToProxyTaxInd>
      <DonorAdvisedFundInd referenceDocumentId="RetDoc2">false</DonorAdvisedFundInd>
      <ConservationEasementsInd referenceDocumentId="RetDoc2">false</ConservationEasementsInd>
      <CollectionsOfArtInd referenceDocumentId="RetDoc2">false</CollectionsOfArtInd>
      <CreditCounselingInd referenceDocumentId="RetDoc2">false</CreditCounselingInd>
      <DonorRstrOrQuasiEndowmentsInd referenceDocumentId="RetDoc2">false</DonorRstrOrQuasiEndowmentsInd>
      <ReportLandBuildingEquipmentInd referenceDocumentId="RetDoc2">false</ReportLandBuildingEquipmentInd>
      <ReportInvestmentsOtherSecInd referenceDocumentId="RetDoc2">false</ReportInvestmentsOtherSecInd>
      <ReportProgramRelatedInvstInd referenceDocumentId="RetDoc2">false</ReportProgramRelatedInvstInd>
      <ReportOtherAssetsInd referenceDocumentId="RetDoc2">false</ReportOtherAssetsInd>
      <ReportOtherLiabilitiesInd referenceDocumentId="RetDoc2">false</ReportOtherLiabilitiesInd>
      <IncludeFIN48FootnoteInd referenceDocumentId="RetDoc2">false</IncludeFIN48FootnoteInd>
      <IndependentAuditFinclStmtInd referenceDocumentId="RetDoc2">true</IndependentAuditFinclStmtInd>
      <ConsolidatedAuditFinclStmtInd referenceDocumentId="RetDoc2">false</ConsolidatedAuditFinclStmtInd>
      <SchoolOperatingInd>false</SchoolOperatingInd>
      <ForeignOfficeInd>false</ForeignOfficeInd>
      <ForeignActivitiesInd>false</ForeignActivitiesInd>
      <MoreThan5000KToOrgInd>false</MoreThan5000KToOrgInd>
      <MoreThan5000KToIndividualsInd>false</MoreThan5000KToIndividualsInd>
      <ProfessionalFundraisingInd>false</ProfessionalFundraisingInd>
      <FundraisingActivitiesInd>false</FundraisingActivitiesInd>
      <GamingActivitiesInd>false</GamingActivitiesInd>
      <OperateHospitalInd>false</OperateHospitalInd>
      <GrantsToOrganizationsInd referenceDocumentId="RetDoc3">true</GrantsToOrganizationsInd>
      <GrantsToIndividualsInd referenceDocumentId="RetDoc3">false</GrantsToIndividualsInd>
      <ScheduleJRequiredInd>false</ScheduleJRequiredInd>
      <TaxExemptBondsInd>false</TaxExemptBondsInd>
      <EngagedInExcessBenefitTransInd>false</EngagedInExcessBenefitTransInd>
      <PYExcessBenefitTransInd>false</PYExcessBenefitTransInd>
      <LoanOutstandingInd>false</LoanOutstandingInd>
      <GrantToRelatedPersonInd>false</GrantToRelatedPersonInd>
      <BusinessRlnWithOrgMemInd>false</BusinessRlnWithOrgMemInd>
      <BusinessRlnWithFamMemInd>false</BusinessRlnWithFamMemInd>
      <BusinessRlnWith35CtrlEntInd>false</BusinessRlnWith35CtrlEntInd>
      <DeductibleNonCashContriInd>false</DeductibleNonCashContriInd>
      <DeductibleArtContributionInd>false</DeductibleArtContributionInd>
      <TerminateOperationsInd>false</TerminateOperationsInd>
      <PartialLiquidationInd>false</PartialLiquidationInd>
      <DisregardedEntityInd>false</DisregardedEntityInd>
      <RelatedEntityInd>false</RelatedEntityInd>
      <RelatedOrganizationCtrlEntInd>false</RelatedOrganizationCtrlEntInd>
      <TrnsfrExmptNonChrtblRltdOrgInd>false</TrnsfrExmptNonChrtblRltdOrgInd>
      <ActivitiesConductedPrtshpInd>false</ActivitiesConductedPrtshpInd>
      <ScheduleORequiredInd>true</ScheduleORequiredInd>
      <IRPDocumentCnt>2</IRPDocumentCnt>
      <IRPDocumentW2GCnt>0</IRPDocumentW2GCnt>
      <EmployeeCnt>0</EmployeeCnt>
      <UnrelatedBusIncmOverLimitInd>false</UnrelatedBusIncmOverLimitInd>
      <ForeignFinancialAccountInd>false</ForeignFinancialAccountInd>
      <ProhibitedTaxShelterTransInd>false</ProhibitedTaxShelterTransInd>
      <TaxablePartyNotificationInd>false</TaxablePartyNotificationInd>
      <NondeductibleContributionsInd>false</NondeductibleContributionsInd>
      <QuidProQuoContributionsInd>false</QuidProQuoContributionsInd>
      <Form8282PropertyDisposedOfInd>false</Form8282PropertyDisposedOfInd>
      <RcvFndsToPayPrsnlBnftCntrctInd>false</RcvFndsToPayPrsnlBnftCntrctInd>
      <PayPremiumsPrsnlBnftCntrctInd>false</PayPremiumsPrsnlBnftCntrctInd>
      <IndoorTanningServicesInd>false</IndoorTanningServicesInd>
      <SubjToTaxRmnrtnExPrchtPymtInd>false</SubjToTaxRmnrtnExPrchtPymtInd>
      <SubjectToExcsTaxNetInvstIncInd>false</SubjectToExcsTaxNetInvstIncInd>
      <InfoInScheduleOPartVIInd>X</InfoInScheduleOPartVIInd>
      <GoverningBodyVotingMembersCnt>6</GoverningBodyVotingMembersCnt>
      <IndependentVotingMemberCnt>6</IndependentVotingMemberCnt>
      <FamilyOrBusinessRlnInd>false</FamilyOrBusinessRlnInd>
      <DelegationOfMgmtDutiesInd>false</DelegationOfMgmtDutiesInd>
      <ChangeToOrgDocumentsInd>false</ChangeToOrgDocumentsInd>
      <MaterialDiversionOrMisuseInd>false</MaterialDiversionOrMisuseInd>
      <MembersOrStockholdersInd>false</MembersOrStockholdersInd>
      <ElectionOfBoardMembersInd>false</ElectionOfBoardMembersInd>
      <DecisionsSubjectToApprovaInd>false</DecisionsSubjectToApprovaInd>
      <MinutesOfGoverningBodyInd>true</MinutesOfGoverningBodyInd>
      <MinutesOfCommitteesInd>true</MinutesOfCommitteesInd>
      <OfficerMailingAddressInd>false</OfficerMailingAddressInd>
      <LocalChaptersInd>false</LocalChaptersInd>
      <Form990ProvidedToGvrnBodyInd>true</Form990ProvidedToGvrnBodyInd>
      <ConflictOfInterestPolicyInd>false</ConflictOfInterestPolicyInd>
      <WhistleblowerPolicyInd>false</WhistleblowerPolicyInd>
      <DocumentRetentionPolicyInd>false</DocumentRetentionPolicyInd>
      <CompensationProcessCEOInd>false</CompensationProcessCEOInd>
      <CompensationProcessOtherInd>false</CompensationProcessOtherInd>
      <InvestmentInJointVentureInd>false</InvestmentInJointVentureInd>
      <StatesWhereCopyOfReturnIsFldCd>UT</StatesWhereCopyOfReturnIsFldCd>
      <UponRequestInd>X</UponRequestInd>
      <BooksInCareOfDetail>
        <PersonNm>TATIANA YUZYUK PHD</PersonNm>
        <PhoneNum>8015832787</PhoneNum>
        <USAddress>
          <AddressLine1Txt>500 CHIPETA WAY</AddressLine1Txt>
          <CityNm>SALT LAKE CITY</CityNm>
          <StateAbbreviationCd>UT</StateAbbreviationCd>
          <ZIPCd>841081221</ZIPCd>
        </USAddress>
      </BooksInCareOfDetail>
      <NoListedPersonsCompensatedInd>X</NoListedPersonsCompensatedInd>
      <Form990PartVIISectionAGrp>
        <PersonNm>ANGELLA CHARNOT-KATSIKAS MD</PersonNm>
        <TitleTxt>IMMEDIATE PA</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>CHRISTOPHER A TORMEY MD</PersonNm>
        <TitleTxt>PAST PRESIDE</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>JONATHAN R GENZEN MD PHD</PersonNm>
        <TitleTxt>PRESIDENT</TitleTxt>
        <AverageHoursPerWeekRt>2.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>RON JACKUPS MD PHD</PersonNm>
        <TitleTxt>SECRETARY</TitleTxt>
        <AverageHoursPerWeekRt>4.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>S WESLEY LONG MD PHD</PersonNm>
        <TitleTxt>PRESIDENT EL</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>TATIANA YUZYUK PHD</PersonNm>
        <TitleTxt>TREASURER</TitleTxt>
        <AverageHoursPerWeekRt>6.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <FormerOfcrEmployeesListedInd>false</FormerOfcrEmployeesListedInd>
      <TotalCompGreaterThan150KInd>false</TotalCompGreaterThan150KInd>
      <CompensationFromOtherSrcsInd>false</CompensationFromOtherSrcsInd>
      <AllOtherContributionsAmt>2154</AllOtherContributionsAmt>
      <TotalContributionsAmt>2154</TotalContributionsAmt>
      <ProgramServiceRevenueGrp>
        <Desc>DUES</Desc>
        <TotalRevenueColumnAmt>39450</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>39450</RelatedOrExemptFuncIncomeAmt>
      </ProgramServiceRevenueGrp>
      <TotalProgramServiceRevenueAmt>39450</TotalProgramServiceRevenueAmt>
      <InvestmentIncomeGrp>
        <TotalRevenueColumnAmt>40276</TotalRevenueColumnAmt>
        <ExclusionAmt>40276</ExclusionAmt>
      </InvestmentIncomeGrp>
      <TotalRevenueGrp>
        <TotalRevenueColumnAmt>81880</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>39450</RelatedOrExemptFuncIncomeAmt>
        <ExclusionAmt>40276</ExclusionAmt>
      </TotalRevenueGrp>
      <GrantsToDomesticOrgsGrp>
        <TotalAmt>22500</TotalAmt>
        <ProgramServicesAmt>22500</ProgramServicesAmt>
      </GrantsToDomesticOrgsGrp>
      <GrantsToDomesticIndividualsGrp>
        <TotalAmt>2800</TotalAmt>
        <ProgramServicesAmt>2800</ProgramServicesAmt>
      </GrantsToDomesticIndividualsGrp>
      <FeesForServicesAccountingGrp>
        <TotalAmt>6200</TotalAmt>
        <ManagementAndGeneralAmt>6200</ManagementAndGeneralAmt>
      </FeesForServicesAccountingGrp>
      <OfficeExpensesGrp>
        <TotalAmt>110</TotalAmt>
        <ProgramServicesAmt>110</ProgramServicesAmt>
      </OfficeExpensesGrp>
      <InformationTechnologyGrp>
        <TotalAmt>16837</TotalAmt>
        <ProgramServicesAmt>16837</ProgramServicesAmt>
      </InformationTechnologyGrp>
      <TravelGrp>
        <TotalAmt>19365</TotalAmt>
        <ProgramServicesAmt>19365</ProgramServicesAmt>
      </TravelGrp>
      <OtherExpensesGrp>
        <Desc>BANK CHARGES</Desc>
        <TotalAmt>12290</TotalAmt>
        <ProgramServicesAmt>12290</ProgramServicesAmt>
      </OtherExpensesGrp>
      <OtherExpensesGrp>
        <Desc>AJCP SUBSCRIPTION FEES</Desc>
        <TotalAmt>5000</TotalAmt>
        <ProgramServicesAmt>5000</ProgramServicesAmt>
      </OtherExpensesGrp>
      <OtherExpensesGrp>
        <Desc>MEMBERSHIP DUES</Desc>
        <TotalAmt>2150</TotalAmt>
        <ManagementAndGeneralAmt>2150</ManagementAndGeneralAmt>
      </OtherExpensesGrp>
      <OtherExpensesGrp>
        <Desc>AWARDS</Desc>
        <TotalAmt>533</TotalAmt>
        <ProgramServicesAmt>533</ProgramServicesAmt>
      </OtherExpensesGrp>
      <AllOtherExpensesGrp>
        <TotalAmt>10</TotalAmt>
        <ManagementAndGeneralAmt>10</ManagementAndGeneralAmt>
      </AllOtherExpensesGrp>
      <TotalFunctionalExpensesGrp>
        <TotalAmt>87795</TotalAmt>
        <ProgramServicesAmt>79435</ProgramServicesAmt>
        <ManagementAndGeneralAmt>8360</ManagementAndGeneralAmt>
        <FundraisingAmt>0</FundraisingAmt>
      </TotalFunctionalExpensesGrp>
      <CashNonInterestBearingGrp>
        <BOYAmt>118808</BOYAmt>
        <EOYAmt>62054</EOYAmt>
      </CashNonInterestBearingGrp>
      <SavingsAndTempCashInvstGrp>
        <BOYAmt>14632</BOYAmt>
        <EOYAmt>25222</EOYAmt>
      </SavingsAndTempCashInvstGrp>
      <InvestmentsPubTradedSecGrp>
        <BOYAmt>1295102</BOYAmt>
        <EOYAmt>1599740</EOYAmt>
      </InvestmentsPubTradedSecGrp>
      <TotalAssetsGrp>
        <BOYAmt>1428542</BOYAmt>
        <EOYAmt>1687016</EOYAmt>
      </TotalAssetsGrp>
      <TotalLiabilitiesGrp>
        <BOYAmt>0</BOYAmt>
        <EOYAmt>0</EOYAmt>
      </TotalLiabilitiesGrp>
      <OrganizationFollowsFASB117Ind>X</OrganizationFollowsFASB117Ind>
      <NoDonorRestrictionNetAssetsGrp>
        <BOYAmt>1428542</BOYAmt>
        <EOYAmt>1687016</EOYAmt>
      </NoDonorRestrictionNetAssetsGrp>
      <TotalNetAssetsFundBalanceGrp>
        <BOYAmt>1428542</BOYAmt>
        <EOYAmt>1687016</EOYAmt>
      </TotalNetAssetsFundBalanceGrp>
      <TotLiabNetAssetsFundBalanceGrp>
        <BOYAmt>1428542</BOYAmt>
        <EOYAmt>1687016</EOYAmt>
      </TotLiabNetAssetsFundBalanceGrp>
      <ReconcilationRevenueExpnssAmt>-5915</ReconcilationRevenueExpnssAmt>
      <NetUnrlzdGainsLossesInvstAmt>264389</NetUnrlzdGainsLossesInvstAmt>
      <MethodOfAccountingAccrualInd>X</MethodOfAccountingAccrualInd>
      <AccountantCompileOrReviewInd>false</AccountantCompileOrReviewInd>
      <FSAuditedInd>true</FSAuditedInd>
      <FSAuditedBasisGrp>
        <SeparateBasisFinclStmtInd>X</SeparateBasisFinclStmtInd>
      </FSAuditedBasisGrp>
      <AuditCommitteeInd>true</AuditCommitteeInd>
      <FederalGrantAuditRequiredInd>false</FederalGrantAuditRequiredInd>
    </IRS990>
    <IRS990ScheduleA documentId="RetDoc5">
      <PubliclySupportedOrg509a2Ind>X</PubliclySupportedOrg509a2Ind>
      <GiftsGrantsContrisRcvd509Grp>
        <CurrentTaxYearMinus4YearsAmt>8998</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>14975</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>2813</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>1150</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>2154</CurrentTaxYearAmt>
        <TotalAmt>30090</TotalAmt>
      </GiftsGrantsContrisRcvd509Grp>
      <GrossReceiptsAdmissionsGrp>
        <CurrentTaxYearMinus4YearsAmt>28100</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>43050</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>31219</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>40550</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>39450</CurrentTaxYearAmt>
        <TotalAmt>182369</TotalAmt>
      </GrossReceiptsAdmissionsGrp>
      <Total509Grp>
        <CurrentTaxYearMinus4YearsAmt>37098</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>58025</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>34032</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>41700</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>41604</CurrentTaxYearAmt>
        <TotalAmt>212459</TotalAmt>
      </Total509Grp>
      <AmountsRcvdDsqlfyPersonGrp>
        <CurrentTaxYearMinus4YearsAmt>5000</CurrentTaxYearMinus4YearsAmt>
        <TotalAmt>5000</TotalAmt>
      </AmountsRcvdDsqlfyPersonGrp>
      <SubstAndDsqlfyPrsnsTotGrp>
        <CurrentTaxYearMinus4YearsAmt>5000</CurrentTaxYearMinus4YearsAmt>
        <TotalAmt>5000</TotalAmt>
      </SubstAndDsqlfyPrsnsTotGrp>
      <PublicSupportTotal509Amt>207459</PublicSupportTotal509Amt>
      <GrossInvestmentIncome509Grp>
        <CurrentTaxYearMinus4YearsAmt>29459</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>27408</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>33152</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>32322</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>40276</CurrentTaxYearAmt>
        <TotalAmt>162617</TotalAmt>
      </GrossInvestmentIncome509Grp>
      <InvestmentIncomeAndUBTIGrp>
        <CurrentTaxYearMinus4YearsAmt>29459</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>27408</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>33152</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>32322</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>40276</CurrentTaxYearAmt>
        <TotalAmt>162617</TotalAmt>
      </InvestmentIncomeAndUBTIGrp>
      <TotalSupportCalendarYearGrp>
        <CurrentTaxYearMinus4YearsAmt>66557</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>85433</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>67184</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>74022</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>81880</CurrentTaxYearAmt>
        <TotalAmt>375076</TotalAmt>
      </TotalSupportCalendarYearGrp>
      <PublicSupportCY509Pct>0.55310</PublicSupportCY509Pct>
      <PublicSupportPY509Pct>0.67400</PublicSupportPY509Pct>
      <InvestmentIncomeCYPct>0.43000</InvestmentIncomeCYPct>
      <InvestmentIncomePYPct>0.30000</InvestmentIncomePYPct>
      <ThirtyThrPctSuprtTestsPY509Ind>X</ThirtyThrPctSuprtTestsPY509Ind>
    </IRS990ScheduleA>
    <IRS990ScheduleD documentId="RetDoc2">
      <TotalRevEtcAuditedFinclStmtAmt>346269</TotalRevEtcAuditedFinclStmtAmt>
      <NetUnrealizedGainsInvstAmt>264389</NetUnrealizedGainsInvstAmt>
      <RevenueNotReportedAmt>264389</RevenueNotReportedAmt>
      <RevenueSubtotalAmt>81880</RevenueSubtotalAmt>
      <TotalRevenuePerForm990Amt>81880</TotalRevenuePerForm990Amt>
      <TotExpnsEtcAuditedFinclStmtAmt>87795</TotExpnsEtcAuditedFinclStmtAmt>
      <ExpensesSubtotalAmt>87795</ExpensesSubtotalAmt>
      <TotalExpensesPerForm990Amt>87795</TotalExpensesPerForm990Amt>
    </IRS990ScheduleD>
    <IRS990ScheduleI documentId="RetDoc3">
      <GrantRecordsMaintainedInd>false</GrantRecordsMaintainedInd>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>YALE UNIVERSITY</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>PO BOX 208234</AddressLine1Txt>
          <CityNm>NEW HAVEN</CityNm>
          <StateAbbreviationCd>CT</StateAbbreviationCd>
          <ZIPCd>065208234</ZIPCd>
        </USAddress>
        <RecipientEIN>060646973</RecipientEIN>
        <IRCSectionDesc>501C3</IRCSectionDesc>
        <CashGrantAmt>7500</CashGrantAmt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>BETH ISREAL DEACONESS MEDICAL CENTE</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>330 BROOKLINE AVE</AddressLine1Txt>
          <CityNm>BOSTON</CityNm>
          <StateAbbreviationCd>MA</StateAbbreviationCd>
          <ZIPCd>02215</ZIPCd>
        </USAddress>
        <RecipientEIN>042103881</RecipientEIN>
        <IRCSectionDesc>501C3</IRCSectionDesc>
        <CashGrantAmt>7500</CashGrantAmt>
        <PurposeOfGrantTxt>RESEARCH</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>UNIVERSITY OF TEXAS</BusinessNameLine1Txt>
          <BusinessNameLine2Txt>MD ANDERSON CENTER</BusinessNameLine2Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>1950 N STEMMONS FREWAY STE 5010</AddressLine1Txt>
          <CityNm>DALLAS</CityNm>
          <StateAbbreviationCd>TX</StateAbbreviationCd>
          <ZIPCd>75207</ZIPCd>
        </USAddress>
        <RecipientEIN>756002868</RecipientEIN>
        <IRCSectionDesc>501C3</IRCSectionDesc>
        <CashGrantAmt>7500</CashGrantAmt>
        <PurposeOfGrantTxt>RESEARCH</PurposeOfGrantTxt>
      </RecipientTable>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>SCHEDULE I, PAGE 1, PART I, LINE 2</FormAndLineReferenceDesc>
        <ExplanationTxt>EACH YEAR, THE FOLLOWING AWARDS ARE GIVEN BY THE ORGANIZATION. COTLOVE LECTURESHIP: PRESENTED TO A SCIENTIST FOR OUTSTANDING CONTRIBUTIONS TO THE SCIENCE OF LABORATORY MEDICINE. GERLAD T. EVANS AWARD: PRESENTED TO A MEMBER OF THE ORGANIZATION TO RECOGNIZE OUTSTANDING LEADERSHIP OR SERVICE TO THE ORGANIZATION. ELLIS BENSON AWARD: PRESENTED TO A YOUNG FACULTY MEMBER IN RECOGNITION OF MERITORIOUS ACCOMPLISHMENT IN THE FIELD OF LABORATORY MEDICINE. PAUL E. STRANDJORD YOUNG INVESTIGATOR AWARD: AWARDED TO A RESIDENT, FELLOW, OR DOCTORAL STUDENT IN HEALTH SCIENCES DESIGNED TO ENCOURAGE THEM TO CONSIDER A CAREER IN ACADEMIC LABORATORY MEDICINE. YOUNG INVESTIGATOR GRANT PROGRAM: AWARDED FOR RESEARCH RELEVANT TO CLINICAL LABORATORY SCIENCE, CLINICAL PATHOLOGY, AND LABORATORY MEDICINE. PROPOSED RESEARCH MAY BE CLINICAL, TRANSLATIONAL, BASIC SCIENCE, QUALITY IMPROVEMENT, AND/OR REGULATORY. AS THIS GRANT PROGRAM IS DESIGNED FOR YOUNG INVESTIGATORS, GRANT RECIPIENTS MUST EITHER BE IN TRAINING (RESIDENCY AND/OR FELLOWSHIP) OR LESS THAN THREE YEARS AFTER THEIR FIRST FACULTY APPOINTMENT (ANY LEVEL) AT THE TIME OF APPLICATION. AWARDEES WILL BE EXPECTED TO PRESENT THEIR RESEARCH AT AN UPCOMING ACLPS ANNUAL MEETING. THE PURPOSE OF THE AWARDS IS TO PROMOTE INVOLVEMENT IN THE PROGRESS OF LABORATORY MEDICINE.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleI>
    <IRS990ScheduleO documentId="RetDoc4">
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990 - ORGANIZATION'S MISSION</FormAndLineReferenceDesc>
        <ExplanationTxt>OUR ACADEMY WAS FOUNDED IN 1966 AND CURRENTLY HAS ACTIVE AFFILIATIONS WITH 70 OF THE APPROXIMATELY 150 ACADEMIC AND COMMUNITY TRAINING CENTERS THAT TRAIN PATHOLOGY RESIDENTS IN CLINICAL PATHOLOGY. FROM ITS ORIGIN, IT HAS FOLLOWED THE MISSION STATEMENT OF BEING DEDICATED TO THE ADVANCEMENT OF TEACHING AND SCHOLARSHIP IN LABORATORY MEDICINE. WE FOLLOW THE OBJECTIVES OF THE ACADEMY. SINCE ITS INCEPTION, THIS DEDICATION HAS BEEN DRIVEN BY THE FOLLOWING OBJECTIVES: 1. TO ENCOURAGE AND ADVANCE THE HIGHEST STANDARDS OF EDUCATION IN LABORATORY MEDICINE IN MEDICAL SCHOOL AND RELATED CURRICULA. 2. TO ENCOURAGE AND PROMOTE THE HIGHEST STANDARDS OF RESIDENT TRAINING AND POST-GRADUATE EDUCATION OF PHYSICIANS AND SCIENTISTS IN CLINICAL PATHOLOGY AT UNIVERSITIES AND MEDICAL SCHOOLS. 3. TO ENCOURAGE AND PROMOTE THE HIGHEST STANDARDS OF SERVICE, EDUCATION AND RESEARCH IN ACADEMIC LABORATORY MEDICINE.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PAGE 2, PART III, LINE 4A</FormAndLineReferenceDesc>
        <ExplanationTxt>DURING THE YEAR THAT ENDED SEPTEMBER 30, 2024, THE ACADEMY PROVIDED SERVICES TO APPROXIMATELY 379 ACTIVE MEMBERS AND 218 ASSOCIATE MEMBERS. CLOSE TO 200 INDIVIDUALS ATTENDED THE ACLPS ANNUAL MEETING ("LAB MEDICINE") IN NEW YORK CITY, NY, ON JUNE 6-8, 2024. THE MEETING WAS HOSTED BY THE COLUMBIA UNIVERSITY DEPARTMENT OF PATHOLOGY. OVER THE THREE DAYS, CONFERENCE ATTENDEES ENJOYED SCIENTIFIC SESSIONS, THE AWARD LECTURES FROM THE COTLOVE AND BENSON AWARDEES, PRESENTATIONS FROM THE YOUNG INVESTIGATOR AWARD WINNERS, THE YOUNG FACULTY AWARD WINNERS AND THE STRANDJORD GRANT AWARDEES, AND A POSTER SESSION. THE REGISTRATION FOR THIS MEETING WAS 725 FOR ACTIVE MEMBERS AND 650 FOR ASSOCIATE MEMBERS. THE COTLOVE AWARD WAS PRESENTED TO DR. DAVID HO, WHO UPDATED THE AUDIENCE ON THE CONTINUING EVOLUTION OF COVID-19 AND HIV. THE BENSON AWARD WAS PRESENTED TO DR. CHRISTOPHER FARNSWORTH WHO SPOKE ON "NOVEL METHODS FOR REDUCING PREANALYTICAL LABORATORY ERROR." THE ACADEMY ALSO CONTINUED THE PAUL E. STRANDJORD YOUNG INVESTIGATOR GRANT PROGRAM THIS YEAR AND PROVIDED THREE 7,500 RESEARCH GRANTS TO PROGRAM AWARDEES IN 2024. ACLPS HAD INITIATED A SERIES OF REVIEW ARTICLES TITLED "ACLPS CRITICAL REVIEWS" PUBLISHED IN AJCP TO REVIEW RELEVANT TOPICS IN THE FIELD OF LABORATORY MEDICINE. IN ADDITION, AS A MEMBER OF THE RISE FIRST CLINICAL PATHOLOGY SECTION, ACLPS EDUCATION COMMITTEE VETTED QUESTIONS FOR THE CLINICAL PATHOLOGY PORTION OF THE EXAM. ACLPS CONTINUED TO SUPPORT CO-SPONSORED EDUCATIONAL SESSIONS AT THE ASCP ANNUAL MEETING. IT IS USUALLY A ONE-HOUR SESSION HIGHLIGHTING EDUCATIONAL TOPICS AND/OR INNOVATIVE RESEARCH IN THE FIELD OF LABORATORY MEDICINE. THE 2024 SPEAKER WAS SEAN STOWELL M.D, PHD WHO GAVE AN EXCELLENT TALK ON ESTABLISHING A NATIONAL BLOOD BANK ALLOANTIBODY REGISTRY. ACLPS CONTINUES TO PROVIDE EDUCATIONAL REVIEW ARTICLES FOR PUBLICATION IN THE AMERICAN JOURNAL OF CLINICAL PATHOLOGY (AJCP).</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PAGE 6, PART VI, LINE 11B</FormAndLineReferenceDesc>
        <ExplanationTxt>THE BOARD OF DIRECTORS IS PROVIDED A DRAFT COPY OF THE FORM 990 TO REVIEW PRIOR TO FILING. THE BOARD CAN ASK QUESTIONS, REQUEST CLARIFICATION, AND MAKE ANY CHANGES.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PAGE 6, PART VI, LINE 19</FormAndLineReferenceDesc>
        <ExplanationTxt>THE ORGANIZATION'S GOVERNING DOCUMENTS AND FINANCIAL STATEMENTS ARE AVAILABLE TO THE PUBLIC UPON REQUEST.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleO>
  </ReturnData>
</Return>